Connect your AI

ClearPoint Neuro CLPT Operating Cash Flow

Operating Cash Flow at other companies

AbbottABT

$1.32B-7.2%

Boston ScientificBSX

$348M-35.7%

IAR

Integra LifeSciencesIART

$9.8M+187%

Zimmer Biomet HoldingsZBH

$359.4M-6.1%

MedtronicMDT

$2.57B+1.8%

Neuropace, Inc.NPCE

-$5.9M+21.1%

Other financials

Income statement

Revenue$12.1M+42.9%

Gross profit$7.8M+51.1%

Operating income-$8.5M-37.6%

Net income-$9.6M-58.5%

EPS (diluted)-$0.32-45.5%

Balance sheet

Cash & equivalents$36.5M+195%

Total debt$63.6M+1,750%

Total equity$18.8M-5.7%

Total assets$93.4M+211%

Cash flow

CapEx$645.0K+252%

Free cash flow-$8.6M-35.5%

Valuation

Market cap$538.61M+69.2%

Enterprise value$565.68M+82.9%

P/S13.3×+3.4×

Profitability

Gross margin62.3%+1.1pp

Operating margin-65.2%-1.9pp

Net margin-71.6%+8.8pp

FCF margin-65.7%+269pp

Returns & leverage

Return on equity-149.7%+4,074pp

Debt / equity3.4×+3.2×

Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ClearPoint Neuro's operating cash flow?: ClearPoint Neuro (CLPT) reported operating cash flow of -$7.97M in Q1 2026.
How has ClearPoint Neuro's operating cash flow changed year-over-year?: ClearPoint Neuro's operating cash flow decreased by 29.1% year-over-year, from -$6.17M to -$7.97M.
What is the long-term trend for ClearPoint Neuro's operating cash flow?: Over 4 years (2021 to 2025), ClearPoint Neuro's operating cash flow has grown at a 17.1% compound annual growth rate (CAGR), from -$12.7M to -$23.9M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.